| Name | Anti-inflammatory agent 22 |
|---|
| Description | Anti-inflammatory agent 22 (compound 14a) is an orally active anti-inflammatory agent. Anti-inflammatory agent 22 inhibits LPS-induced TNF-α production with an IC50 value of 14.6 μM. Anti-inflammatory agent 22 has preventive effects on lymphedematous tissue via suppression of adipogenesis. Anti-inflammatory agent 22 suppresses limb lymphedema volume in mice[1]. |
|---|---|
| Related Catalog | |
| Target |
TNF-α:14.6 μM (IC50) |
| References |
| Molecular Formula | C22H16O6 |
|---|---|
| Molecular Weight | 376.36 |